Goodwin Biotechnology
Natalia Bourguignon, Ph.D. is currently the Manager of Upstream Manufacturing Sciences and Technology at GBI Bio. Prior to this, Natalia worked as a Research Assistant Professor at Florida International University and as a Scientific Researcher at CONICET. Natalia has a strong background in microfluidics technologies and has conducted research in various areas such as bioremediation, monoclonal antibodies, and cell-based therapies. With a PhD in Biological Sciences and postdoctoral degrees in Microfluidics and Biotechnology, Natalia is a highly skilled professional in their field.
Goodwin Biotechnology
Goodwin Biotechnology, Inc. (GBI), based near Fort Lauderdale, Florida, is a fully integrated, customer-focused cGMP Contract Manufacturing Organization (CMO) of Biosimilar and innovative monoclonal antibodies, recombinant proteins, vaccines, Antibody Drug Conjugates (ADCs), and other bioconjugates.